课题基金 / 基金详情

Cancer-Stromal Interaction in Lung Adenocarcinoma

Cancer-Stromal Interaction in Lung Adenocarcinoma
肺腺癌中的癌症-间质相互作用
批准号:
10670223
负责人:
NIKI Toshiro
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

NIKI Toshiro的其他基金

相似基金

相关文献

中文摘要
翻译
VEGF家族是一组调节内皮细胞生长的生长因子。研究表明VEGF-A参与肿瘤的侵袭和转移。采用定量RT-PCR方法检测60例肺腺癌组织中VEGF-A、-B、-C和-D的表达水平,探讨其表达水平与肺腺癌淋巴结转移的关系。我们发现有淋巴结转移的肿瘤与低VEGF-D和高VEGF-A、VEGF-B和VEGF-C的模式相关。此外,大淋巴结转移的肿瘤中VEGF-A的水平高于小淋巴结转移的肿瘤,而VEGF-B或VEGF-C的水平则无差异。这些结果与两个VEGF家族成员参与两个不同步骤的假设一致; VEGF-C促进癌细胞进入淋巴管,而VEGF-A通过血管生成促进转移性肿瘤的生长。层粘连蛋白-5蛋白是已知促进癌细胞运动的细胞外基质蛋白。总的来说,层粘连蛋白-5的表达在82例观察:7/18支气管肺泡癌和75/84浸润性腺癌。层粘连蛋白-5优先定位于肿瘤-基质界面处的肿瘤细胞的细胞质中,其中经常观察到癌细胞的出芽或解离。生存分析显示,层粘连蛋白-5的过度表达(24例,23.5%)是一个独立的预后因素,在单因素和多因素分析。进一步的体外实验表明,肺腺癌细胞系中层粘连蛋白-5 γ2链mRNA水平与erbB-2表达和MAPK磷酸化相关。TGF-α、HGF、TNF-α和IL-1 β以时间依赖性方式增加层粘连蛋白5 γ 2链mRNA水平。
英文摘要
The VEGF family is a group of growth factors that regulate the growth of endothelial cells. Studies suggest that VEGF-A is involved in tumor invasion and metastasis. We investigated the expression levels of VEGF-A, -B, -C, and -D in 60 cases of lung adenocarcinomas by quantitative RT-PCR analyses, and explored whether their expression levels were correlated with lymph node metastasis. We found that tumors with lymph node metastasis were associated with a pattern of low VEGF-D and high VEGF-A, VEGF-B, and VEGF-C.Also, levels of VEGF-A, but not of VEGF-B or VEGF-C, were higher in tumors with large nodal metastasis than in those with small nodal metastasis. These results are consistent with the hypothesis that two VEGF family members are involved at two distinct steps ; VEGF-C facilitates entry of cancer cells into lymph vasculature, whereas VEGF-A promotes the growth of metastatic tumor through angiogenesis.Next, we immunohistochemically investigated the expression of laminin-5 in 102 cases of small lung adenocarcinomas. The laminin-5 protein is an extracellular matrix protein that is known to facilitate motility of cancer cells. Overall, laminin-5 expression was observed in 82 cases : 7 of 18 bronchiolo-alveolar carcinomas and 75 of 84 invasive adenocarcinomas. Laminin-5 was preferentially localized in the cytoplasm of tumor cells at the tumor-stromal interface, where budding or dissociation of cancer cells was frequently observed. Survival analysis revealed that over-expression of laminin-5 (24 cases, 23.5%) was an independent prognostic factor in both univariate and multivariate analyses. Further in vitro experiments showed that laminin-5 γ2 chain mRNA levels were correlated with erbB-2 expression and MAPK phosphorylation in lung adenocarcinoma cell lines. Treatment with TGF-α, HGF, TNF-α, and IL-1 β increased the laminin-5 γ 2 chain mRNA levels in a time-dependent manner.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Yasumitu Moriya,Toshiro Niki, et al.: "Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size"Cancer. (In press). (2001)
Yasumitu Moriya、Toshiro Niki 等人:“层粘连蛋白 5 的表达增加及其在小尺寸肺腺癌中的预后意义”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of molecular target and its therapeutic application for micropapillary adenocarcinoma
  • 批准号:
    23659189
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.25万
  • 财政年份:
    2011
  • 负责人:
    NIKI Toshiro
  • 依托单位:
Molecular targets for lung adenocarcinoma with epithelial-mesenchymal transition : identification and their application for diagnosis and therapy.
  • 批准号:
    20390103
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $7.65万
  • 财政年份:
    2008
  • 负责人:
    NIKI Toshiro
  • 依托单位:
Investigation of genes induced at the invasive front of lung adenocarcinomas
  • 批准号:
    17590294
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.37万
  • 财政年份:
    2005
  • 负责人:
    NIKI Toshiro
  • 依托单位:
国内基金
海外基金
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
  • 批准号:
    2026JJ80680
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    姜平
  • 依托单位:
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
  • 批准号:
    JCZRLH202601503
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
  • 批准号:
    2026JJ80684
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    龚攀
  • 依托单位: